Reference : Oral glucose tolerance tests in schizophrenic patients treated with antipsychotics
Scientific congresses and symposiums : Paper published in a journal
Social & behavioral sciences, psychology : Neurosciences & behavior
Human health sciences : Neurology
Oral glucose tolerance tests in schizophrenic patients treated with antipsychotics
De Hert, Marc [> > > >]
Van Eyck, Dominique [> > > >]
Hermans, Gilberte [Centre Hospitalier Universitaire de Liège - CHU > > Anatomie pathologique >]
Peuskens, Hendrik [> > > >]
Wampers, Martien [> > > >]
de Patoul, A. [> > > >]
Hanssens, L. [> > > >]
Scheen, André mailto [Université de Liège - ULg > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale]
Peuskens, Jozef [> > > >]
International Journal of Neuropsychopharmacology
Cambridge Univ Press
Suppl. 1
Yes (verified by ORBi)
New York
[en] Schizophrenia ; Diabetes ; Metabolic syndrome; ; Antipsychotics
[en] Objective. –A recent consensus conference has proposed guidelines for the monitoring for diabetes in patients with schizophrenia and also
identifies the need of long-term prospective studies.
Method. – A large scale prospective study on metabolic risks of antipsychotic medication is currently ongoing. At baseline, patients get a
full laboratory screening, ECG and an oral glucose tolerance test (OGTT). Baseline data on 100 non-diabetic patients at study inclusion and
stable on medication for at least 6 months are presented.
Results. – Glucose abnormalities are found in 22% of patients at baseline.A monitoring protocol based only on fasting glucose would not
have detected 63.6% of these patients with classifiable glucose abnormalities in our sample. Fasting insulin and measures for insulin resistance
have a high predictive value for abnormalities late in the OGTT.
Conclusion. – Already at baseline, metabolic problems are frequently present in patients with schizophrenia treated with antipsychotics.
Adding assessment of fasting insulin in a monitoring protocol improves detection of glucose abnormalities late in an OGTT.
Researchers ; Professionals ; Students
© 2005 Elsevier SAS. All rights reserved.

File(s) associated to this reference

Fulltext file(s):

Open access
de hert ogtt 200 bl European Psychiatry June 2006 21(4)224-6 de hert et al.pdfNo commentaryPublisher postprint86.32 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.